Crystec Pharma is focused on applying supercritical fluid technology to improve the performance of medicines. We provide crystal and particle engineering solutions to the pharmaceutical industry, contributing to human health by enabling new and more effective therapies. Applications of our mSAS® (modified Supercritical Anti-Solvent) technology include enhancing the dissolution and bioavailability of drugs, optimising release profiles, as well as improving stability and processing characteristics. Our solutions include the following: • Crystal and particle engineering • Stabilisation of therapeutic agents derived from biotechnology • Polymorph screening • Improved performance of poorly soluble drugs • Improved bioavailabilty of small molecules • Alternative routes of delivery such as inhaled therapy • Taste masking • Crystallisation seeds • Residual solvent elimination
View Top Employees from CrystecPharmaWebsite | http://www.crystecpharma.com |
Revenue | $4 million |
Employees | 17 (15 on RocketReach) |
Phone | +44 1274 235592 |
Technologies |
JavaScript,
HTML,
PHP
+18 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Biopharma, Manufacturing, Biotechnology, Health Care, Science and Engineering, Pharmaceutical |
Web Rank | 15 Million |
Keywords | Chemical Companies In Leeds |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular CrystecPharma employee's phone or email?
The CrystecPharma annual revenue was $4 million in 2024.
Lyn Daintree is the Development Director of CrystecPharma.
15 people are employed at CrystecPharma.
The NAICS codes for CrystecPharma are [32541, 32, 3254, 325].
The SIC codes for CrystecPharma are [28, 283].